Avita Medical Inc Expected To Post A Loss Of 25 Cents A Share: Earnings Preview

AVITA Medical

06/08/2025 24:14

AVITA Medical Inc RCEL.OQ RCEL.O is expected to  show a rise in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

The Valencia California California-based  company is expected to report a 48.8% increase in revenue to $22.609 million from $15.2 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for AVITA Medical Inc is for a loss of 25 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for AVITA Medical Inc is $16.50, about 68% above its last closing price of $5.28

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.38
-0.38
-0.53
Missed
-37.7
Dec. 31 2025
-0.49
-0.43
-0.44
Missed
-1.6
Sep. 30 2024
-0.44
-0.44
-0.62
Missed
-42.1​
Jun. 30 2024
-0.52
-0.52
-0.60
Missed
-15.8
​​Mar. 31 2024
-0.45
-0.47
-0.73
Missed
-54.3
Dec. 31 2023
-0.36
-0.37
-0.28
Beat
25.2​
Sep. 30 2023
-0.45
-0.44
-0.34
Beat
23.4
Jun. 30 2023
-0.32
-0.32
-0.41
Missed
-26.4

This summary was machine generated August 5 at 23:14 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)